Published in J Clin Invest on April 01, 1985
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension (2015) 2.01
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension (2013) 1.55
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol (2010) 1.39
Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab (2012) 0.97
Prenatal betamethasone exposure alters renal function in immature sheep: sex differences in effects. Am J Physiol Regul Integr Comp Physiol (2010) 0.96
Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk. Hypertension (2014) 0.88
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 0.84
Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. Curr Opin Endocrinol Diabetes Obes (2014) 0.80
Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study. BMC Endocr Disord (2013) 0.79
Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts. Br J Clin Pharmacol (1987) 0.76
THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY. J Clin Invest (1938) 56.55
Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med (1979) 2.31
Accentuated vascular and endocrine response to SQ 20881 in hypertension. N Engl J Med (1977) 1.83
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest (1980) 1.76
Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med (1973) 1.65
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med (1977) 1.64
The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med (1972) 1.62
Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest (1974) 1.59
Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43
Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol (1980) 1.36
Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet (1979) 1.34
Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension (1981) 1.31
Regulation by angiotensin II of its receptors in resistance blood vessels. Nature (1980) 1.24
Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int (1981) 1.20
Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest (1983) 1.16
Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13
Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res (1977) 1.12
A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion. J Clin Invest (1974) 0.93
Parallel adrenal and renal abnormalities in young patients with essential hypertension. Am J Med (1982) 0.93
Altered renin-angiotensin-aldosterone relationships in normal renin essential hypertension. Circ Res (1977) 0.92
Renal responses of Australian lungfish to vasotocin, angiotensin II, and NaCl infusion. Am J Physiol (1976) 0.91
Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. J Clin Invest (1979) 0.90
The antihypertensive effect of captopril. Evidence for an influence of kinins. Hypertension (1981) 0.90
Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. J Clin Endocrinol Metab (1983) 0.88
Endocrine profile in the long-term phase of converting-enzyme inhibition. Clin Pharmacol Ther (1980) 0.81
Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension. Hypertension (1984) 0.79
Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition. J Hypertens Suppl (1983) 0.77
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group. N Engl J Med (1993) 4.62
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med (1987) 2.83
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res (1999) 2.49
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med (1980) 2.15
Spontaneous recurrent hypothermia accompanying agenesis of the corpus callosum. Brain (1969) 2.10
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med (1981) 1.97
Cdc6 protein causes premature entry into S phase in a mammalian cell-free system. EMBO J (1998) 1.95
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Accentuated vascular and endocrine response to SQ 20881 in hypertension. N Engl J Med (1977) 1.83
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res (1998) 1.81
Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest (1980) 1.76
Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med (1973) 1.65
Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension (1999) 1.64
The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med (1972) 1.62
Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest (1974) 1.59
Familial hypo-beta-lipoproteinemia: a genetic disorder of lipid metabolism with nervous system involvement. Am J Med (1969) 1.51
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology (2000) 1.50
Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med (1984) 1.49
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1997) 1.46
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43
Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43
Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysate. Hypertension (1997) 1.42
Glucocorticoid-remediable aldosteronism. Cardiovasc Res (1996) 1.38
The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol (1999) 1.38
Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res (2001) 1.34
Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension (1981) 1.31
Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med (1977) 1.31
beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction. Circ Res (1976) 1.28
Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28
Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol (2001) 1.28
Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension. N Engl J Med (1979) 1.27
Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med (1976) 1.27
Cardiac output distribution in the rat: comparison of rubidium and microsphere methods. Am J Physiol (1971) 1.27
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation (1993) 1.26
Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet (1999) 1.24
Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension (1981) 1.23
Regulation of aldosterone secretion. Annu Rev Physiol (1988) 1.20
Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading. J Clin Invest (1972) 1.20
Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab (1975) 1.20
Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int (1981) 1.20
Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest (1975) 1.16
Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest (1983) 1.16
Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J Clin Invest (1976) 1.16
Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens (1996) 1.16
Heterogenous inositol tetrakisphosphate binding sites in the adrenal cortex. J Biol Chem (1988) 1.15
Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Arch Intern Med (1999) 1.15
24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry (2000) 1.15
Characterization of smooth muscle receptors for angiotensin: studies with an antagonist. Am J Physiol (1974) 1.13
Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13
Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens (2001) 1.12
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension (1998) 1.12
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer (2005) 1.12
Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. J Hypertens (1992) 1.12
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens (2006) 1.12
The renal circulation in hypertensive disease. Am J Med (1976) 1.12
A simple radioactive microsphere method for measuring regional flow and cardiac output. Invest Radiol (1974) 1.10
Melatonin rhythm observed throughout a three-cycle bright-light stimulus designed to reset the human circadian pacemaker. J Biol Rhythms (1999) 1.09
Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion. J Clin Invest (1972) 1.09
A primate model of hyperacute renal allograft rejection. Am J Pathol (1975) 1.09
Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension (1999) 1.09
Calcium oscillations in single adrenal glomerulosa cells stimulated by angiotensin II. Proc Natl Acad Sci U S A (1988) 1.04
The role of vasoconstriction in the ischemia of renal allograft rejection. Transplantation (1968) 1.04
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. Br J Cancer (2009) 1.04
Abnormal responsiveness of the renin aldosterone system to acute stimulation in patients with essential hypertension. Ann Intern Med (1970) 1.03
Renal vascular responses to angiotensin and norepinephrine in normal man. Effect of sodium intake. Circ Res (1972) 1.02
Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. Am J Med (1981) 1.02
Quality of life and its impact on hypertensive patients. Am J Med (1987) 1.02
Screening for postpartum depression. An antepartum questionnaire. J Reprod Med (1997) 1.02
Acute renal failure due to nephrotoxins. N Engl J Med (1970) 1.02
Is there a future for renin inhibitors? Expert Opin Investig Drugs (2001) 1.01
In vivo staining of the kidney with Alcian blue: an adjunct to morphological and physiological studies. Ren Physiol (1983) 1.01
Electrical properties of isolated rat adrenal glomerulosa and fasciculata cells. Endocrinology (1987) 1.01
Effect of sodium intake on insulin sensitivity. Am J Physiol (1993) 1.01
Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. Am J Cardiol (1992) 1.01
Angiotensin-converting enzyme inhibition and prostaglandins. Am J Cardiol (1982) 1.00
Cortical ischemia in renal allograft rejection. Surg Gynecol Obstet (1967) 1.00
Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol (2007) 1.00